Westlake Chemical Partners price to sales ratio WLKP
Market value divided by revenue over the last twelve months, since 2015.
- Today, Oct 23, 2026
- 0.6×
- 10-year median
- 0.7×
- Against its 10-year history
- 25th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 0.4× to 1.0×
- Peer median
- 1.3×
Westlake Chemical Partners' price to sales ratio is 0.6× as of Oct 23, 2026.
That is below its ten-year median of 0.7×, lower than on 75% of days in the last ten years.
Over that time it ranged from 0.4× in Mar 2020 to 1.0× in Apr 2021.
The median for 7 specialty chemicals stocks of a similar size is 1.3×.
Price to sales ratio over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 0.6× | 0.6× | 0.7× |
| 2025 | 0.6× | 0.6× | 0.8× |
| 2024 | 0.7× | 0.6× | 0.7× |
| 2023 | 0.6× | 0.5× | 0.6× |
| 2022 | 0.5× | 0.5× | 0.9× |
| 2021 | 0.8× | 0.7× | 1.0× |
| 2020 | 0.8× | 0.4× | 0.8× |
| 2019 | 0.8× | 0.6× | 0.8× |
| 2018 | 0.6× | 0.5× | 0.8× |
| 2017 | 0.7× | 0.6× | 0.7× |
| 2016 | 0.6× | 0.4× | 0.7× |
| 2015 | 0.6× | 0.4× | 0.6× |
Against its peers
Companies in Chemicals - Specialty nearest Westlake Chemical Partners' size, closest first, today.
| Company | Price to sales ratio |
|---|---|
| WLKPWestlake Chemical Partners | 0.6× |
| LXULSB Industries | 1.1× |
| GPREGreen Plains | 0.5× |
| LXFRLuxfer | 1.3× |
| REXREX AMERICAN RESOURCES | 2.0× |
| ALTOAlto Ingredients | 0.3× |
| SXTSensient Technologies | 3.3× |
| AXTAAxalta Coating Systems | 1.4× |
| Peer median | 1.3× |
Where Westlake Chemical Partners ranks
What the price to sales ratio tells you
Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.
Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.
More on Westlake Chemical Partners
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.